Soft tissue tumors and treatment
Soft tissue tumors and treatment is a research topic within Pathology and Forensic Medicine. Science Explorer counts 9.1k research works in it since 1950. 5.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical, molecular, and genetic characteristics of glomus tumors, including atypical and malignant variants. It covers topics such as diagnosis, imaging modalities, surgical approaches, and the association with neurofibromatosis type 1.
- Glomus Tumors
- Angioleiomyoma
- Gastrointestinal Glomus Tumors
- Malignant Glomus Tumor
- Genetic Mutations
- Clinical Diagnosis
- Radiological Imaging
- Surgical Treatment
- Soft Tissue Tumors
- Neurofibromatosis Type 1
- Research works
- 9.1k fractional, since 1950
- In the world top 10%
- 504 per year above
- Top-10% rate
- 5.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +6% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Soft tissue tumors and treatment research?
By volume, the United States and India publish the most (262 and 202 works in 2022–2025).
By volume, 2022–2025
- 1 United States 262 works
- 2 India 202 works
- 3 China 146 works
- 4 Japan 95 works
- 5 Spain 50 works
- 6 Brazil 47 works
- 7 South Korea 41 works
- 8 Italy 38 works
- 9 United Kingdom 37 works
- 10 Türkiye 36 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Soft tissue tumors and treatment research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Soft tissue tumors and treatment research, followed by Mayo Clinic in Arizona and Institute of Medical Sciences.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 10 works
- 2 Mayo Clinic in ArizonaUnited States 7 works
- 3 Institute of Medical SciencesIndia 6 works
- 4 Dr. D. Y. Patil Medical College, Hospital and Research CentreIndia 6 works
- 5 Sichuan UniversityChina 5 works
- 6 Centre Hospitalier Universitaire Ibn RochdMorocco 5 works
- 7 Iran University of Medical SciencesIran 5 works
- 8 Creative CommonsUnited States 4 works
- 9 Post Graduate Institute of Medical Education and ResearchIndia 4 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 4 works
Where is Soft tissue tumors and treatment research done?
The largest centres of Soft tissue tumors and treatment research in 2022–2025 are New Delhi (India), Beijing (China), Seoul (South Korea) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in New Delhi.
Largest cities, 2022–2025
Where it is the local speciality
- New DelhiIN · 26.0 works4.1×
Location quotient: how much more of its research is in Soft tissue tumors and treatment than the world average.
Where is the best place to study Soft tissue tumors and treatment?
Among universities, judged by research, All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia | 0.0 | 7.3% | 12.3× | 10 | +35.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Soft tissue tumors and treatment research growing?
Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Soft tissue tumors and treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.